Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Rachel H. Albright, Robert M. Joseph, Dane K. Wukich, David G. Armstrong, Adam E. Fleischer

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?'. Together they form a unique fingerprint.

Medicine & Life Sciences